isabelobrien, Author at European Medical Journal - Page 30 of 68

Researchers

UK improves global clinical trial ranking, but hurdles remain

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

Dr Cecilia Caetano, Bayer

Bayer’s Dr Cecilia Caetano on making space for menopause

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

GSK drug shows promise in multiple myeloma

A trial has shown that belantamab mafodotin can reduce the risk of death by 42% in patients with relapsed or refractory multiple myeloma.

Coin stacks

Amgen expands biomanufacturing footprint in North Carolina

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.

white house on blue background

Biden-Harris Administration expands access to sickle cell disease treatments

In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.

Ed Smith

Onc Now: Episode 6: Revolutionising Paediatric Radiation Oncology – Part 1

Join Ed Smith, Professor at the University of Manchester, UK, to discuss the revolutionary potential of proton beam therapy and radiation oncology.

The word spotlight on a blue background

Spotlight: November 2024

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.

ABPI calls for MHRA reform to drive UK life sciences growth

As the MHRA begins a new chapter, the ABPI has published a report outlining the importance of regulatory excellence in the UK.

Season 8 highlights: GOLD Medal Moments

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the series just gone?

cancer illustration

Novocure’s Phase III trial shows promise for pancreatic cancer

The Phase 3 PANOVA-3 trial has shown that adding Tumor Treating Fields therapy to standard chemotherapy improved survival in patients.